Dechert Recognized by Financial Times Among Innovative Law Firms in North America  

December 05, 2016

The Financial Times has ranked Dechert LLP among the top 10 most innovative firms in North America for innovating to solve clients' business challenges in its 2016 "North America Innovative Lawyers" report.

The annual report, which combines the Financial Times' independent journalism with extensive research carried out by RSG Consulting, recognizes "highly innovative" firms whose lawyers have "made a critical contribution to transforming their clients' businesses." Firms are judged on the originality of their legal work, the rationale behind strategy and the impact of their work on a client's business.

Firms are also recognized for innovative strategies towards managing themselves as businesses, engaging and developing talent, and delivering services to clients.

Overall, Dechert was ranked as the eighth most innovative law firm in North America at an awards ceremony held at the New York Public Library on December 5.

“We are proud that the depth of our expertise and talent has been recognized by the Financial Times,” said Henry N. Nassau, Dechert's Chief Executive Officer. "Dechert lawyers bring fresh thinking, sound commercial judgment and a relentless focus on our clients' interests to the table every day. These awards are a public recognition of those efforts."

Boston-based patent strategist Andrea L.C. Reid was honored as one of just 10 individuals shortlisted as "Legal Innovator of the Year." Reid, who designed new drug candidates, developed novel processes for drug manufacturing and amassed 14 U.S. patents as an inventor before becoming a lawyer, now counsels life sciences clients on IP policies, patent portfolio management and filing strategies. Her strategies have resulted in acquisition and investor/partner funding worth more than US$5.5 billion.

Reid also won the "Legal Expertise" category entitled "Enabling Clients to Innovate" for her work on behalf of drug discoverer Nimbus Therapeutics. Reid's innovative IP strategy underpinned Nimbus' sale of an ACC-inhibitor drug program focused on fatty liver disease to Gilead Sciences for an aggregate deal value of US$1.2 billion.

The firm also won the "Innovation in Social Responsibility: Pro Bono Cases" category for its efforts to combat diplomatic involvement in the trafficking of domestic workers. Since winning a landmark case that established federal precedent in limiting diplomatic immunity for human traffickers, trial lawyer Amy Rudd and other Dechert attorneys have continued to represent servants and domestic workers as they seek safety and justice.

Dechert's innovative antitrust tool "DAMITT" finished a very strong second in the "Data, Analytics & Intelligence" category – just one point behind the winner. The tool, a comprehensive database developed by partners Paul Denis and Michael Weiner and associate Rani Habash, was "Highly Commended" for tracking the number and duration of significant antitrust merger investigations in the United States.

Achieving "Commended" status in the "Changing and Influencing Regulation" category were the firm's activities toward the issue of credit risk retention in asset management. Dechert's global CLO team, co-led by partners Cindy Williams and John Timperio, not only devised innovative strategies and capital structures to help CLO managers comply with the new rules but also led the terms of debate with a sustained thought leadership campaign.

Dechert is one of just two firms to have made the FT10 in both North America and Europe this year. In October 2016, Dechert was also recognized by the Financial Times as a leading firm for innovation in the “European Innovative Lawyers” report.

Read the full Financial Times North America Innovative Lawyers 2016 report.

About Dechert

Dechert is a global specialist law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.

Subscribe to Dechert Updates